Cardiorenal effects of adenosine subtype 1 (A1) receptor inhibition in an experimental model of heart failure (Q44001565)

28 November 2017

title

Cardiorenal effects of adenosine subtype 1 (A1) receptor inhibition in an experimental model of heart failure (English)

1 reference

28 November 2017

David G Lucas

1

1 reference

28 November 2017

Jennifer W Hendrick

2

1 reference

28 November 2017

Jeffrey A Sample

3

1 reference

28 November 2017

Rupak Mukherjee

4

1 reference

28 November 2017

Gladys P Escobar

5

1 reference

28 November 2017

Glenn J Smits

6

1 reference

28 November 2017

Fred A Crawford

7

1 reference

28 November 2017

Francis G Spinale

8

1 reference

28 November 2017

publication date

1 May 2002

1 reference

Journal of the American College of Surgeons

28 November 2017

published in

1 reference

28 November 2017

volume

194

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

603-609

1 reference

Plasma adenosine levels increase in patients with chronic heart failure

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901136-5

7 January 2021

Increased myocardial adenosine release in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901136-5

7 January 2021

Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901136-5

7 January 2021

Comparison of interstitial fluid and coronary venous adenosine levels in in vivo porcine myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901136-5

7 January 2021

Adenosine receptors and signaling in the kidney

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901136-5

7 January 2021

Changes in left ventricular volume, mass, and function during the development and regression of supraventricular tachycardia-induced cardiomyopathy. Disparity between recovery of systolic versus diastolic function

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901136-5

7 January 2021

Haemodynamic and neurohumoral response in heart failure produced by rapid ventricular pacing

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901136-5

7 January 2021

Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901136-5

7 January 2021

Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: results of the Studies of Left Ventricular Dysfunction (SOLVD) Registry. The SOLVD Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901136-5

7 January 2021

Synthesis and biological evaluation of the enantiomers of the potent and selective A1-adenosine antagonist 1,3-dipropyl-8-[2-(5,6-epoxynorbonyl)]-xanthine

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901136-5

7 January 2021

Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901136-5

7 January 2021

Effects of adenosine receptor subtype A1 on ventricular and renal function

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901136-5

7 January 2021

Adenosine receptors mediate both contractile and relaxant effects of adenosine in main pulmonary artery of guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901136-5

7 January 2021

Cardiovascular and Renal Effects of Blocking A1 Adenosine Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901136-5

7 January 2021

Diuretic and saliuretic effects of 1,3-dipropyl-8-cyclopentylxanthine, a selective A1-adenosine receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901136-5

7 January 2021

Adenosine A1 antagonists. 2. Structure-activity relationships on diuretic activities and protective effects against acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901136-5

7 January 2021

Adenosine: a physiological brake on renin release

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901136-5

7 January 2021

Myocardial adaptation to ischaemia--the preconditioning phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901136-5

7 January 2021

Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901136-5

7 January 2021

Loss of myocardial protection from ischemic preconditioning following chronic exposure to R(-)-N6-(2-phenylisopropyl)adenosine is related to defect at the adenosine A1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901136-5

7 January 2021

Effects of A1 adenosine receptor blockade by bamiphylline on ischaemic preconditioning during coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901136-5

7 January 2021

10.1016/S1072-7515(02)01136-5

Identifiers

DOI

1 reference

28 November 2017

1 reference